Testing a shingles shield for transplant patients
NCT ID NCT06162494
Summary
This study is testing the safety and immune response of the shingles vaccine in young adults who have received organ transplants like a heart, liver, or kidney. Participants will receive two doses of the vaccine and be monitored for side effects and their body's immune reaction over about a year. The goal is to see if the vaccine is safe and effective for people whose immune systems are suppressed by transplant medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VARICELLA ZOSTER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ann & Robert H. Lurie Children's Hospital
Chicago, Illinois, 60611, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
Conditions
Explore the condition pages connected to this study.